Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Takahide Toyoda

Assistant Professor

Chiba University Graduate School of Medicine
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. Takahide Toyoda is an Assistant Professor in the Department of General Thoracic Surgery at Chiba University Graduate School of Medicine, Japan. His research focuses on lung surgery, including techniques for lung segmentectomy and management of complications in lung transplantation. His recent publications explore innovative approaches to improve surgical outcomes and address challenges in transplant medicine, particularly in relation to graft dysfunction and patient rehabilitation.

Articles (12)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Purpose Managing acute respiratory distress syndrome (ARDS) patients on venovenous extracorporeal membrane oxygenation (V‐V ECMO), without sedation/neuromuscular blockade to allow physical and occupational therapy (PT/OT) participation, is untraditional. Here, we investigate the impact of early PT/OT initiation on discharge functional activity for ARDS patients managed on V‐V ECMO. Methods This is a retrospective review of 67 ARDS patients managed with V‐V ECMO at a single academic center from February 2018 to June 2021. Data collected included patient characteristics, days of V‐V ECMO support, day of PT/OT initiation, and ambulation distance and Activity Measure for Post‐Acute Care (AMPAC) Six‐Clicks score on day of discharge. Results Patients with >7 days of V‐V ECMO support had decreased ambulation and AMPAC scores compared to those with <7 days (70.5 vs. 162.1, p < 0.01 and 12.3 vs. 16.4, p = 0.01, respectively). PT/OT initiation within 7 days after starting V‐V ECMO significantly improved ambulation and AMPAC scores (163.5 vs. 59.5, p < 0.001, and 16.6 vs. 11.8, p < 0.01, respectively). Additionally, in patients with >7 days of V‐V ECMO support, those who began PT/OT within 8 days of V‐V ECMO cannulation had significantly improved ambulation and AMPAC scores (151.8 vs. 44.2, p < 0.01, and 16.5 vs. 11.0, p < 0.01, respectively). Conclusion Early PT/OT initiation in severe ARDS patients managed on V‐V ECMO is associated with improved patient functional activity on day of discharge. Our study further supports the use of V‐V ECMO in treatment of severe ARDS without sedation/neuromuscular blockade and specifically demonstrates PT/OT should be started early following V‐V ECMO cannulation.

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Chitaru Kurihara

-

UNITED STATES
View details

Yuanqing Yan

Research Assistant Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Samuel Kim

Associate Professor Surgery

Northwestern University Feinberg School of Medicine

UNITED STATES
View details